Filter
666
Filtered Results: 666
Text search:
experimental
drug
Featured
Recommendations
53
New Publications
118
Language
Document type
No document type
385
Studies & Reports
113
Guidelines
92
Manuals
36
Strategic & Response Plan
12
Training Material
9
Fact sheets
9
Situation Updates
5
Resource Platforms
4
Brochures
1
Countries / Regions
India
32
Global
24
Western and Central Europe
17
Latin America and the Carribbean
14
Rwanda
13
Sierra Leone
11
Kenya
11
South Africa
11
Ethiopia
10
Congo, Democratic Republic of
8
Uganda
8
Ghana
7
Liberia
6
Tanzania
6
Ukraine
6
Colombia
6
Nigeria
5
Zimbabwe
5
Philippines
5
Nepal
5
Germany
5
Bangladesh
5
Argentina
5
Brazil
5
Venezuela
5
Eastern Europe
5
South Sudan
4
Eswatini/ Swaziland
4
South–East Asia Region
4
Africa
4
Russia
4
USA
3
Zambia
3
Indonesia
3
Malawi
3
Peru
3
Ecuador
3
Lesotho
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
Burkina Faso
2
Senegal
2
Cameroon
2
Haiti
2
Namibia
2
Eastern Europe and Central Asia
2
Tajikistan
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Syria
1
Thailand
1
China
1
Mozambique
1
Botswana
1
Bolivia
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Paraguay
1
Asia
1
Canada
1
Uzbekistan
1
Spain
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
65
Public Health
41
Women & Child Health
16
Key Resources
14
Pharmacy & Technologies
10
Capacity Building
9
Toolboxes
Mental Health
123
COVID-19
55
TB
51
Ebola
46
HIV
42
NTDs
38
Rapid Response
29
Pharmacy
26
AMR
20
Caregiver
18
Planetary Health
16
NCDs
13
Disability
11
Global Health Education
6
Zika
5
Conflict
3
Refugee
3
Health Financing Toolbox
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
Accessed: 22.03.2019
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in ...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support the development and improvement of substance abuse tr...
Revista Peruana de Medicina Experimental y Salud Pública 2017 Vol 34 (2)
En el presente artículo se desarrolla la situación epidemiológica de la TB en el Perú al 2015, los avances en su control, de acuerdo a tres enfoques: biomédico, de gesti...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential com...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-... interaction panel and now consists of six main sections, including a general overview table of all major issues in PLWH, recommendations on antiretroviral treatment, drug-drug interactions, diagnosis, monitoring and treatment of co-morbidities, co-infections and opportunistic diseases.
Available in English, French, Spanish, German, Portuguese, Russian, Chinese and Japanese
Alcohol, medication, tobacco, illegal drugs, addictive behaviour
Second, revised edition with new layout
Juni 2014
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggest...
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International ... Monitoring. This text was developed in consultation with the WHO Collaborating Centre for International Drug Monitoring and the national pharmacovigilance centres participating in the WHO Programme for International Drug Monitoring.
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental med...
Overview.
The COVID-19 pandemic is the latest crisis facing the world, but unless humans release their grip on nature, it won’t be the last, according to a new report by the United Nations Development Programme (UNDP), which includes a new experimental<...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved ...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
